Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12617807 | Long lasting opioid reversal using hydrogen peroxide-induced release in blood | 🖼🧊📄§ | 2026-05-05 | 2042-04-01 | 0 | 31 |
| 12616673 | Compounds for use in the treatment of leukemia | 🖼🧊📄§ | 2026-05-05 | 2041-01-28 | 0 | 31 |
| 12617866 | Humanized antibodies to mucin-16 and methods of use thereof | 🖼🧊📄§ | 2026-05-05 | 2040-05-07 | 0 | 31 |
| 12616688 | Cell glycocalyx protection effect of anisodamine | 🖼🧊📄§ | 2026-05-05 | 2041-09-01 | 0 | 31 |
| 12616667 | Compositions and methods for improving neurological diseases and disorders | 🖼🧊📄§ | 2026-05-05 | 2042-11-14 | 0 | 31 |
| 12616669 | Methods and chemical compositions for treating skin conditions by providing long lasting skin pH control for improving skin barrier function | 🖼🧊📄§ | 2026-05-05 | 2045-08-27 | 0 | 31 |
| 12618082 | Engineered muscle targeting compositions | 🖼🧊📄§ | 2026-05-05 | 2042-03-29 | 0 | 31 |
| 12617862 | Anti-CD73 antibody and application thereof | 🖼🧊📄§ | 2026-05-05 | 2040-08-20 | 0 | 31 |
| 12620468 | Personalized liver cancer treatment | 🖼🧊📄§ | 2026-05-05 | 2045-03-06 | 0 | 31 |
| 12617809 | Cardioprotective lipid and method of use | 🖼🧊📄§ | 2026-05-05 | 2042-09-22 | 0 | 31 |
| 12616652 | Lenses for treating ocular diseases and preparation method thereof | 🖼🧊📄§ | 2026-05-05 | 2042-12-29 | 0 | 31 |
| 12617828 | Genetically modified immune cell, preparation method therefor, and application | 🖼🧊📄§ | 2026-05-05 | 2040-05-06 | 0 | 31 |
| 12616734 | Chimeric antigen receptor specifically binding to cd 300C antigen or receptor thereof | 🖼🧊📄§ | 2026-05-05 | 2042-05-27 | 0 | 31 |
| 12617755 | Compositions and methods for treating metabolic disease | 🖼🧊📄§ | 2026-05-05 | 2040-08-03 | 0 | 31 |
| 12612358 | Resorcinol-based compounds and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2041-12-16 | 0 | 31 |
| 12611462 | Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereof | 🖼🧊📄§ | 2026-04-28 | 2042-07-14 | 0 | 31 |
| 12611433 | Anaerostipes sp B2131 strain and application thereof in inflammatory bowel diseases | 🖼🧊📄§ | 2026-04-28 | 2041-01-08 | 0 | 31 |
| 12612426 | Aryl glucoside derivative | 🖼🧊📄§ | 2026-04-28 | 2040-11-24 | 0 | 31 |
| 12612464 | Autoantibody specifically binding to NELL-1 and elevated NELL-1 polypeptide levels for identifying and treating membranous nephropathy | 🖼🧊📄§ | 2026-04-28 | 2040-09-18 | 0 | 31 |
| 12611412 | Targeting the TLK1/NEK1 axis in prostate cancer | 🖼🧊📄§ | 2026-04-28 | 2043-11-15 | 0 | 31 |
| 12612462 | Treatment and inhibition of inflammatory lung diseases in patients having risk alleles in the genes encoding IL33 and IL1RL1 | 🖼🧊📄§ | 2026-04-28 | 2043-06-07 | 0 | 31 |
| 12611378 | Targeted release rifaximin compositions | 🖼🧊📄§ | 2026-04-28 | 2041-06-25 | 0 | 31 |
| 12612447 | April and BAFF inhibitory immunomodulatory proteins and methods of use thereof | 🖼🧊📄§ | 2026-04-28 | 2043-03-17 | 0 | 31 |
| 12611440 | Fusion proteins and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2040-09-03 | 0 | 31 |
| 12611443 | Methods and compositions related to therapeutic peptides for cancer therapy | 🖼🧊📄§ | 2026-04-28 | 2041-06-14 | 0 | 31 |
| 12611405 | Agent that increases the expression of the BCL2-associated agonist of cell death for the treatment of cancer | 🖼🧊📄§ | 2026-04-28 | 2038-03-28 | 0 | 31 |
| 12612431 | Cyclic compounds for treating cancer | 🖼🧊📄§ | 2026-04-28 | 2042-06-10 | 0 | 31 |
| 12611429 | Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy | 🖼🧊📄§ | 2026-04-28 | 2042-08-03 | 0 | 31 |
| 12612459 | Methods of identifying agents that block MCD28 cleavage by MMPS | 🖼🧊📄§ | 2026-04-28 | 2040-12-02 | 0 | 31 |
| 12611458 | Chimeric receptors and methods of use thereof | 🖼🧊📄§ | 2026-04-28 | 2043-04-14 | 0 | 31 |
| 12612389 | Benzofuran-based N-acylhydrazone derivative and pharmaceutical composition comprising same | 🖼🧊📄§ | 2026-04-28 | 2040-07-14 | 0 | 31 |
| 12612385 | Compounds and methods for targeting pathogenic blood vessels | 🖼🧊📄§ | 2026-04-28 | 2043-11-27 | 0 | 31 |
| 12612362 | Anisomycin derivative and use of anisomycin and derivative thereof as GLP-1R agonist | 🖼🧊📄§ | 2026-04-28 | 2043-07-24 | 0 | 31 |
| 12611431 | Approach to sustained production and delivery of nitric oxide and S-nitrosothiols | 🖼🧊📄§ | 2026-04-28 | 2043-10-16 | 0 | 31 |
| 12611386 | Extended release pharmaceutical formulation | 🖼🧊📄§ | 2026-04-28 | 2041-09-22 | 0 | 31 |
| 12612439 | Mutant bacteriorhodopsin-like-channelrhodopsin ion channel | 🖼🧊📄§ | 2026-04-28 | 2043-02-03 | 0 | 31 |
| 12611448 | Targeting delivery system loaded with whole-cell components and use thereof | 🖼🧊📄§ | 2026-04-28 | 2040-11-05 | 0 | 31 |
| 12612449 | HIV-1 antibodies | 🖼🧊📄§ | 2026-04-28 | 2041-06-10 | 0 | 31 |
| 12611425 | Compositions and methods for treatment and prevention of pathogens | 🖼🧊📄§ | 2026-04-28 | 2043-08-14 | 0 | 31 |
| 12611438 | Antiviral composition comprising a nucleolin-binding peptide | 🖼🧊📄§ | 2026-04-28 | 2042-05-18 | 0 | 31 |
| 12612629 | Duchenne muscular dystrophy-related exonic splicing enhancer, sgRNA and gene editing tool, and applications | 🖼🧊📄§ | 2026-04-28 | 2040-09-30 | 0 | 31 |
| 12612460 | Anti-PD-1 antibodies and fusion proteins | 🖼🧊📄§ | 2026-04-28 | 2044-12-20 | 0 | 31 |
| 12611444 | IL-36 cytokine expressing oncolytic viruses for treating cancer | 🖼🧊📄§ | 2026-04-28 | 2042-03-17 | 0 | 31 |
| 12611423 | Medical use of tafoxiparin | 🖼🧊📄§ | 2026-04-28 | 2043-05-02 | 0 | 31 |
| 12612463 | Mesothelin-targeted CD40 agonistic multispecific antibody constructs for the treatment of solid tumors | 🖼🧊📄§ | 2026-04-28 | 2044-01-19 | 0 | 31 |
| 12611434 | Bifidobacterium brevis and its application in preventing or alleviating psoriasis thereof | 🖼🧊📄§ | 2026-04-28 | 2043-06-21 | 0 | 31 |
| 12611457 | Bispecific antibodies specifically binding to PD1 and LAG3 | 🖼🧊📄§ | 2026-04-28 | 2042-03-07 | 0 | 31 |
| 12611395 | Use of carbamate compound for preventing or treating trigeminal neuralgia | 🖼🧊📄§ | 2026-04-28 | 2041-12-02 | 0 | 31 |
| 12611418 | Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin | 🖼🧊📄§ | 2026-04-28 | 2045-08-11 | 0 | 31 |
| 12611430 | Therapeutic agent of peripheral blood flow disorder | 🖼🧊📄§ | 2026-04-28 | 2039-11-29 | 0 | 31 |